Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore ...
to twice-daily azelastine (an intranasal antihistamine), fluticasone propionate, the combination of the two, or placebo for 2 weeks during the allergy season; all treatments were administered as ...
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...
The state and the defense presented their final witnesses Tuesday in the manslaughter trial of Dixie Denise Villa, accused of giving a fatal dose of diphenhydramine, the antihistamine found in ...
Hives tend to go away without treatment, but self-care strategies like taking a cooling bath can help manage discomfort. Some people, however, may require medication such as an antihistamine, ...